<keyword id="19895063" type="General" weightage="20" keywordseo="India" source="keywords">India</keyword>'s <keyword id="20068546" type="General" weightage="20" keywordseo="bioeconomy" source="keywords">bioeconomy</keyword> has experienced significant growth, reaching a valuation of USD 151 billion by the end of 2023, according to a new report, which said that the surge highlights the bioeconomy's critical role in national development, contributing 4.25 per cent to the country's GDP and positioning India among the top five global bioeconomies. The report, prepared by the <keyword id="20068545" type="General" weightage="20" keywordseo="biotechnology" source="keywords">Biotechnology</keyword> Industry Research Assistance Council (<keyword id="22722619" type="General" weightage="20" keywordseo="BIRAC" source="keywords">BIRAC</keyword>) and the Association of Biotechnology Led Enterprises (ABLE), outlines transformative advances across biotechnology, agricultural innovation, healthcare, and <keyword id="22906123" type="General" weightage="20" keywordseo="biomanufacturing" source="keywords">biomanufacturing</keyword>, driving the sector's expansion. It was released during a session at the Global Bio-India Summit 2024. The report said that India's bioeconomy has experienced significant growth, reaching a valuation of USD 151 billion by the end of 2023. "This surge highlights the bioeconomy's critical role in national development, contributing 4.25 per cent to the country's GDP and positioning India among the top five global bioeconomies," it said. One of the major drivers of this growth has been the BioE3 (Biotechnology for Economy, Environment, and Employment) Policy, the report said, noting that the policy focuses on bio-based chemicals, precision biotherapeutics, climate-resilient agriculture, and advanced research in marine and space technologies. Rajesh S Gokhale, Secretary DBT, Chairman BIRAC &amp; DG-BRIC said the India bioeconomy report 2024, launched at the 4th edition of Global Bio India, marks a pivotal moment in India's journey to becoming a global leader in biotechnology. "The report underscores India's bioeconomy growth from USD 10 billion in 2014 to USD 151 billion by 2023, driven by rising demand for vaccines and biopharmaceuticals. With the new BioE3 Policy, we are poised to accelerate this momentum, aiming to reach USD 300 billion by 2030. This report sets the foundation for India's bio-revolution and highlights our path towards global leadership in biotechnology," Gokhale told PTI. The report also emphasises the use of Artificial Intelligence (AI) in biomanufacturing, with plans to create biomanufacturing and Bio-AI hubs. These efforts are expected to create new employment opportunities, particularly in tier-II and tier-III cities, while supporting the integration of biotechnology across various industries, the report said. The Bioindustrial sector remains the largest contributor to India's bioeconomy, accounting for USD 72.6 billion or 48.09 per cent of the total market, the report said. This sector includes biofuels, bioplastics, and enzymatic applications in industries such as textiles and detergents. Biofuels, in particular, have seen a sharp rise, with ethanol production capacity increasing to 13.8 billion litres in 2023, making India the world's third-largest producer of ethanol. The Ethanol Blended Petrol (EBP) programme, which promotes domestic ethanol production, has been central to reducing India's dependency on imported fuels and enhancing energy security, the report added. The biopharma sector also saw impressive growth, contributing USD 53.8 billion or 35.65 per cent to the bioeconomy. India's vaccine manufacturing capacity continues to be a global leader, with companies like Serum Institute of India (SII) producing over 3 billion doses annually. Major breakthroughs, such as the R21/Matrix-M malaria vaccine and India's first quadrivalent Human Papillomavirus (HPV) vaccine, have highlighted India's prowess in vaccine production. The diagnostics and medical devices segment, which grew to USD 19.4 billion, has also played a crucial role in addressing healthcare challenges, particularly through advancements in early disease detection and personalized medicine, the report said. In the bioagri sector, which accounted for USD 12.44 billion (8.24 per cent), agricultural biotechnology continues to drive innovations in sustainable farming practices. Precision agriculture technologies, such as genetically modified crops and bio-based products like biopesticides, are being increasingly adopted to enhance agricultural productivity. "Bt cotton remains a key example of how biotechnology is improving crop resilience and yields, contributing to sustainable agriculture growth in India," the report said. India's bioservices sector, valued at USD 12.1 billion (8.02 per cent), has emerged as a critical support system for the bioeconomy, providing contract research, clinical trials, and biotech software services, the report said. "This segment grew by 30 per cent in 2023, reflecting India's expanding role as a global hub for research and development. The sector's growth is expected to continue, with increasing demand for outsourced research and specialised bioservices that help accelerate product commercialisation," the report added. Looking ahead, the report said India's bioeconomy is expected to continue its robust expansion, targeting a valuation of USD 300 billion by 2030. "This growth will be driven by advancements in sectors like bioindustrial, biopharma, and bioagri, along with strategic government policies such as the BioE3 initiative. The bioeconomy is also projected to support over 35,000 startups and create 35 million jobs by the end of the decade, underscoring its potential as a key driver of India's sustainable development and economic growth," it said. SEE ALSO: <a href="https://www.businessinsider.in/stock-market/webstories/western-carriers-ipo-price-band-to-risk-factors-all-you-need-to-know/slidelist/113312196.cms">Western Carriers IPO – Price band to risk factors, all you need to know</a> <a href="https://www.businessinsider.in/stock-market/news/pn-gadgil-jewellers-ipo-allotment-how-to-check-allotment-ipo-gmp-listing-date-and-more/articleshow/113302533.cms">PN Gadgil Jewellers IPO allotment – How to check allotment, IPO GMP, listing date and more</a> <a href="https://www.businessinsider.in/tech/mobile/news/iphone-16-pro-is-already-cheaper-than-the-iphone-15-pro-in-india-but-you-can-get-it-for-up-to-30000-cheaper/articleshow/113220789.cms">iPhone 16 Pro is already cheaper than the iPhone 15 Pro in India, but you can get it for up to ₹30,000 cheaper</a>

India's bioeconomy reaches valuation of $151 billion, contributes 4.25%  to GDP: Report

New Delhi: <keyword id="19895063" type="General" weightage="20" keywordseo="India" source="keywords">India</keyword>'s <keyword id="20068546" type="General" weightage="100" keywordseo="bioeconomy" source="keywords">bioeconomy</keyword> has experienced significant growth, reaching a valuation of USD 151 billion by the end of 2023, according to a new report, which said that the surge highlights the bioeconomy's critical role in national development, contributing 4.25 per cent to the country's GDP and positioning India among the top five global bioeconomies. The report, prepared by the <keyword id="20068545" type="General" weightage="20" keywordseo="biotechnology" source="keywords">Biotechnology</keyword> Industry Research Assistance Council (<keyword id="22722619" type="General" weightage="20" keywordseo="BIRAC" source="keywords">BIRAC</keyword>) and the Association of Biotechnology Led Enterprises (<keyword id="23152831" type="General" weightage="20" keywordseo="ABLE" source="keywords">ABLE</keyword>), outlines transformative advances across biotechnology, agricultural innovation, healthcare, and <keyword id="22906123" type="General" weightage="20" keywordseo="biomanufacturing" source="keywords">biomanufacturing</keyword>, driving the sector's expansion. It was released during a session at the <keyword id="23139986" type="General" weightage="20" keywordseo="Global-Bio-India-Summit" source="keywords">Global Bio-India Summit</keyword> 2024. The report said that India's bioeconomy has experienced significant growth, reaching a valuation of USD 151 billion by the end of 2023. "This surge highlights the bioeconomy's critical role in national development, contributing 4.25 per cent to the country's GDP and positioning India among the top five global bioeconomies," it said. One of the major drivers of this growth has been the BioE3 (Biotechnology for Economy, Environment, and Employment) Policy, the report said, noting that the policy focuses on bio-based chemicals, precision biotherapeutics, climate-resilient agriculture, and advanced research in marine and space technologies. It also emphasizes the use of Artificial Intelligence (AI) in biomanufacturing, with plans to create biomanufacturing and Bio-AI hubs. These efforts are expected to create new employment opportunities, particularly in tier-II and tier-III cities, while supporting the integration of biotechnology across various industries, the report said. The Bioindustrial sector remains the largest contributor to India's bioeconomy, accounting for USD 72.6 billion or 48.09 per cent of the total market, the report said. This sector includes biofuels, bioplastics, and enzymatic applications in industries such as textiles and detergents. Biofuels, in particular, have seen a sharp rise, with <keyword id="20069651" type="General" weightage="20" keywordseo="ethanol" source="keywords">ethanol</keyword> production capacity increasing to 13.8 billion litres in 2023, making India the world's third-largest producer of ethanol. The Ethanol Blended Petrol (EBP) programme, which promotes domestic ethanol production, has been central to reducing India's dependency on imported fuels and enhancing energy security, the report added. The <keyword id="20071168" type="General" weightage="20" keywordseo="biopharma" source="keywords">Biopharma</keyword> sector also saw impressive growth, contributing USD 53.8 billion or 35.65 per cent to the bioeconomy. India's vaccine manufacturing capacity continues to be a global leader, with companies like Serum Institute of India (SII) producing over 3 billion doses annually. Major breakthroughs, such as the R21/Matrix-M malaria vaccine and India's first quadrivalent Human Papillomavirus (HPV) vaccine, have highlighted India's prowess in vaccine production. The diagnostics and medical devices segment, which grew to USD 19.4 billion, has also played a crucial role in addressing healthcare challenges, particularly through advancements in early disease detection and personalized medicine, the report said. In the Bioagri sector, which accounted for USD 12.44 billion (8.24 per cent), agricultural biotechnology continues to drive innovations in sustainable farming practices. Precision agriculture technologies, such as genetically modified crops and bio-based products like biopesticides, are being increasingly adopted to enhance agricultural productivity. "Bt cotton remains a key example of how biotechnology is improving crop resilience and yields, contributing to sustainable agriculture growth in India," the report said. India's bioservices sector, valued at USD 12.1 billion (8.02 per cent), has emerged as a critical support system for the bioeconomy, providing contract research, clinical trials, and biotech software services, the report said. "This segment grew by 30 per cent in 2023, reflecting India's expanding role as a global hub for research and development. The sector's growth is expected to continue, with increasing demand for outsourced research and specialised bioservices that help accelerate product commercialisation," the report added. Looking ahead, the report said India's bioeconomy is expected to continue its robust expansion, targeting a valuation of USD 300 billion by 2030. "This growth will be driven by advancements in sectors like bioindustrial, biopharma, and bioagri, along with strategic government policies such as the BioE3 initiative. The bioeconomy is also projected to support over 35,000 startups and create 35 million jobs by the end of the decade, underscoring its potential as a key driver of India's sustainable development and economic growth," it said.

India's bioeconomy reaches valuation of USD 151 billion, contributes 4.25 percent to GDP: Report

<ul class="summary-list"><li>The top US <keyword id="12538255" type="UNKNOWN" weightage="60" keywordseo="counterintelligence" source="Orion">counterintelligence</keyword> agency recently published a list of five tech sectors it says are vital to US interests.</li><li>Those sectors are also vulnerable to adversaries, according to the National Counterintelligence and Security Center.</li></ul>The US's top counterintelligence and security agency recently published a list of five technology sectors vital to US national and economic security that it says are vulnerable to malicious actors and adversaries.According to the National Counterintelligence and Security Center, those <a href="https://www.dni.gov/files/NCSC/documents/SafeguardingOurFuture/FINAL_NCSC_Emerging%20Technologies_Factsheet_10_22_2021.pdf" target="_top">five prized sectors</a> are <keyword id="11896615" type="UNKNOWN" weightage="60" keywordseo="artificial-intelligence" source="Orion">artificial intelligence</keyword>, bioeconomy, autonomous systems, quantum information science and technology, and semiconductors."These sectors produce technologies that may determine whether America remains the world's leading superpower or is eclipsed by strategic competitors in the next few years," the NCSC says.Although the threat mainly comes from near-peer adversaries, such as <keyword id="11892748" type="UNKNOWN" weightage="60" keywordseo="china" source="Orion">China</keyword> and <keyword id="11894337" type="UNKNOWN" weightage="60" keywordseo="russia" source="Orion">Russia</keyword>, it isn't limited to those countries. In addition to publishing the list, the US intelligence community is contacting private industry with advice and training to protect US national security and the US's competitive advantages.<h2>Artificial intelligence</h2><div type="image" title="artificial intelligence robot" height="2986" width="4479" msid="87720058" hostid="261"></div>Artificial intelligence is a constellation of technologies that demonstrate cognition and creative problem-solving, essentially enabling machines to perform the tasks of humans.Uses for AI range from narrow applications designed to solve specific problems to broad applications, such as Artificial General Intelligence, that have the potential to match or even exceed the understanding and learning abilities of humans.Artificial intelligence also has many military applications. The F-35 stealth fighter jet relies heavily on artificial intelligence for many of its functions. Compromising that technology could undermine or negate many of the jet's capabilities.Artificial intelligence is also key to bulk data collection. The NSA, for example, uses it to quickly process and help analyze the immense amount of data it collects daily.<h2>Quantum information science and technology</h2><div type="image" title="quantum computing google" height="1177" width="1980" msid="87720059" hostid="261"></div>This technology uses the fundamental properties of matter to create new information technologies. For example, quantum computers use atoms and photons to accelerate some kinds of problem-solving.Quantum-related technology has been used in the development of semiconductor microelectronics, the global positioning system, and magnetic resonance imaging.Quantum technology could also have a critical impact on cryptography, or the encryption and decryption of communications. Were China to gain an advantage in quantum, it could target the essential encrypted communications of the US military, intelligence agencies, and private sector."In short, whoever wins the race for <keyword id="11901318" type="UNKNOWN" weightage="60" keywordseo="quantum-computing" source="Orion">quantum computing</keyword> supremacy could potentially compromise the communications of others," the NCSC states.<h2>Bioeconomy</h2><div type="image" title="biotechnology lab" height="3270" width="5448" msid="87720060" hostid="261"></div>Bioeconomy is economic activity related to and driven by research and innovation in <keyword id="12538257" type="UNKNOWN" weightage="60" keywordseo="biotechnology" source="Orion">biotechnology</keyword>.The US bioeconomy improves many aspects of daily life, such as food and healthcare. It can also present a serious threat to national security and even humanity.China is aggressively collecting domestic and foreign DNA material to gain an advantage in biotechnology and for more sinister reasons. The uniqueness of DNA makes it virtually impossible for a person or group to hide from an oppressive surveillance state like China.Genomic technology that is designed to treat diseases can also be used against specific individuals or whole populations.<h2>Semiconductors</h2><div type="image" title="FILE PHOTO - A researcher plants a semiconductor on an interface board during a research work to design and develop a semiconductor product at Tsinghua Unigroup research centre in Beijing, China, February 29, 2016. REUTERS/Kim Kyung-Hoon" height="2400" width="3600" msid="87720061" hostid="261"></div>These small pieces of technology have become essential to most aspects of modern life, powering military technology such as satellites and stealth fighter jet and consumer products integral to everyday activity, such as TV and toasters.The lighter, faster, and cheaper a semiconductor is, the better it is, and global nature of the semiconductor supply chain raises challenges to ensuring steady access for the US, which is reliant on Taiwan and China for most of those chips.Adversaries have targeted the US semiconductor industry, draining talent and resources, and future attacks on that supply chain could further undermine the US economy."Since semiconductors are such key components, the fragile supply chain for semiconductors puts virtually every sector of the economy at risk of disruption," the NCSC says.<h2>Autonomous Systems</h2><div type="image" title="Navy MQ-8B Fire Scout drone helicopter" height="1429" width="2000" msid="87720063" hostid="261"></div>Unmanned systems perform tasks without or with limited human intervention or control, though many of them, such as remotely piloted aircraft or unmanned undersea vehicles, require some human involvement.Such systems can improve productivity and safety for humans, but those systems' reliance on software, computing, and connectivity creates opportunities for malicious cyberattacks against them. They're also vulnerable to supply-chain disruptions.Foreign and malicious actors can also target autonomous systems for intelligence gathering, using malicious software to compromise them.<h2>Beijing and Moscow</h2><div type="image" title="putin xi" height="1956" width="3000" msid="87720064" hostid="261"></div>China and Russia are the main threats to the above five tech sectors.Beijing seeks global leadership in those and other technologies by 2030, and has pursued that goal through several avenues, including legal means and outright theft. The Kremlin also views the development of advanced science and technology as national security and strategic priority.Both countries employ various methods to get their hands on such technologies, including operations by their intelligence services, investments in private companies, promotion of academic collaboration and research partnerships, and luring top talent.A transformation in intelligence collection is driving Beijing's and Moscow's targeting of these five sectors. During the Cold War, adversary intelligence agencies went after classified military and intelligence secrets, but now they have shifted toward the private sector."If you look back 20 years ago, what we were most concerned about was intelligence services targeting the US government for classified information or targeting DOD technologies," Mike Orlando, acting director of the NCSC, said in an <a href="https://www.cbsnews.com/news/foreign-espionage-threats-u-s-intelligence-matters-podcast/" target="_top">interview</a> earlier this year."What we've seen over the last 20 years is the shift to private-sector intellectual-property research and development, particularly by China, who has been the most egregious one in stealing those technologies," Orlando added.Stavros Atlamazoglou is a defense journalist specializing in special operations, a Hellenic Army veteran (national service with the 575th Marine Battalion and Army HQ), and a Johns Hopkins University graduate.

5 kinds of technology that the US's top spy catchers say rivals are gaining an edge in

<ul class="summary-list"><li>Xiang Haitao, 44, worked for <keyword id="12903561" type="UNKNOWN" weightage="60" keywordseo="monsanto" source="Orion">Monsanto</keyword> in <keyword id="11911042" type="UNKNOWN" weightage="60" keywordseo="missouri" source="Orion">Missouri</keyword> from 2008 to 2017.</li><li>The <keyword id="12098051" type="UNKNOWN" weightage="60" keywordseo="doj" source="Orion">DOJ</keyword> said he stole a secret algorithm before leaving and planned to pass it to <keyword id="11892748" type="UNKNOWN" weightage="60" keywordseo="china" source="Orion">China</keyword>.</li></ul>A Chinese scientist has admitted stealing trade secrets from the agrochemical giant Monsanto, <a href="https://www.justice.gov/opa/pr/chinese-national-pleads-guilty-economic-espionage-conspiracy">the Justice Department said Thursday</a>.Xiang Haitao, 44, worked as an imaging scientist for Monsanto in Missouri between 2008 and 2017, during which time Monsanto and its subsidiary The Climate Corporation worked on a secret algorithm known as the "Nutrient Optimizer," the department said, citing court documents.The algorithm helped farmers their productivity, the DOJ said.Before leaving the company, Xiang downloaded a copy of the algorithm, and then flew to China on a one-way ticket, the department said.Law-enforcement officers searched Xiang's electronics at the airport, but he was ultimately allowed to leave the US, the department said. Investigators later concluded that "one of Xiang's electronic devices contained copies of the Nutrient Optimizer," the DOJ said.US law-enforcement officials were able to arrest Xiang after he returned to the US sometime between 2017 and 2019, the department said.Xiang pleaded guilty to conspiracy to commit economic espionage on Thursday, the department said. He faces a maximum sentence of 15 years in prison and a potential $5 million fine.In China, Xiang went on to work for the Institute of Soil <keyword id="11896083" type="UNKNOWN" weightage="60" keywordseo="science" source="Orion">Science</keyword> at the state-run Chinese Academy of Science in Nanjing, the DOJ said.The department said Xiang intended to pass the stolen materials on to the Chinese government. It is unclear if the government was able to make use of the "Nutrient Optimizer.""Despite Xiang's agreements to protect Monsanto's intellectual property and repeated training on his obligations to do so, Xiang has now admitted that he stole a trade secret from Monsanto, transferred it to a memory card and attempted to take it to the People's Republic of China for the benefit of Chinese government," Assistant Attorney General Matthew G. Olsen said in a statement.In October, the US National Counterintelligence and Security Center identified bioeconomy as one of the key areas where China is trying to steal US intelligence, as <a href="https://www.businessinsider.com/us-spy-catchers-russia-china-gaining-edge-in-key-tech-2021-11">Insider's Stavros Atlamazoglou previously reported.</a>"These sectors produce technologies that may determine whether America remains the world's leading superpower or is eclipsed by strategic competitors in the next few years," the NCSC said.Tom Armitage, a spokesperson for Bayer, which owns Monsanto, told Insider: "The protection of intellectual property is essential for innovation across industries."After Xiang was indicted by a grand jury in 2019, <a href="https://www.courthousenews.com/chinese-national-denies-stealing-monsanto-trade-secrets/">China's foreign ministry said</a> the US was using the case to make the baseless claim that China conducts widespread espionage in the US."We resolutely oppose the US side's attempts to use the case, which we regard as an ordinary, isolated incident, to hype up claims of China's organized and systematic attempts to steal intellectual property from the US," spokesman Geng Shuang said.

A Chinese scientist in Missouri admitted stealing a secret algorithm from Monsanto to pass to Beijing

<ul class="summary-list"><li>A new "COVID-proof" <keyword id="513113" type="COMPANY" weightage="60" keywordseo="smart-city">smart city</keyword> is being planned in <keyword id="1334" type="COUNTRY" weightage="60" keywordseo="China">China</keyword>.</li><li>The development, built by Spanish architects Guallart, has been designed with future lockdowns in mind.</li><li>The community in Xiong'an will feature apartments with balconies, a terrace for drone deliveries, co-working spaces, a vegetable garden, greenhouse, and food market.</li></ul>A new "COVID-proof" city is being planned in China, designed for people to live in during future lockdowns.<div type="image" title="Ciudad autosuficiente_foto Guallart Architects (3)" height="1125" width="2000" msid="78039449" hostid="261"></div>Spanish architects Guallart won a competition to build the community in Xiong'an, and the hope is it will be a model for "a new standard in the post-COVID era" that can be used in cities around the world.Designed as a "self-sufficient city," the development is set to include apartments with large balconies, vegetable gardens, greenhouses, solar panels, communal workspaces, a pool, food market, kindergarten, and drone-friendly terraces designed for deliveries.<div type="image" title="Ciudad autosuficiente_foto Guallart Architects (18)" height="1125" width="2000" msid="78039453" hostid="261"></div>Many of the streets will be reserved for pedestrians and cyclists, and there will be lots of greenery.The idea is to provide "a full life in times of confinement," a press release reads.<div type="image" title="Ciudad autosuficiente_foto Guallart Architects (11)" height="1125" width="2000" msid="78039460" hostid="261"></div>"We cannot continue designing cities and buildings as if nothing had happened," Guallart said."Our proposal stems from the need to provide solutions to the various crises that are taking place in our planet at the same time, in order to create a new urban life based in the circular bioeconomy that will empower cities and communities."<div type="image" title="Ciudad autosuficiente_foto Guallart Architects (15)" height="1414" width="2000" msid="78039462" hostid="261"></div>The buildings will have an "internal metabolic system" that will integrate energy production, recycled water, food production, and material reuse to promote <keyword id="49089" type="ORGANIZATION" weightage="60" keywordseo="Sustainability">sustainability</keyword>.

You Searched For "bioeconomy" and got 5 results

India's bioeconomy reaches valuation of $151 billion, contributes 4.25% to GDP: Report

PTI

India's bioeconomy reaches valuation of USD 151 billion, contributes 4.25 percent to GDP: Report

PTI

5 kinds of technology that the US's top spy catchers say rivals are gaining an edge in

Stavros Atlamazoglou

A Chinese scientist in Missouri admitted stealing a secret algorithm from Monsanto to pass to Beijing

Bill Bostock

China is building a high-tech 'COVID-proof' smart city designed for future lockdowns

Rachel Hosie